TATTENHAM HEALTH CENTRE
TATTENHAM CRESCENT, EPSOM
CKD 4
The percentage of patients on the CKD register with hypertension who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 80 | 94 | 85.1% | |
| CKD 4 | 2008 | 79 | 88 | 89.8% | |
| CKD 5 | 2009 | 12 | 13 | 92.3% | |
| CKD 5 | 2010 | 9 | 10 | 90.0% | |
| CKD 5 | 2011 | 9 | 10 | 90.0% | |
| CKD 5 | 2012 | 6 | 7 | 85.7% | |
| CKD 5 | 2013 | 5 | 6 | 83.3% | |
| CKD003 | 2014 | 6 | 6 | 100.0% | |
| CKD003 | 2015 | 5 | 5 | 100.0% | |
| NM84 | 2017 | 3 | 6 | 50.0% | |
| NM84 | 2018 | 4 | 6 | 66.7% | |
| NM84 | 2022 | 6 | 7 | 85.7% | |
| NM84 | 2023 | 7 | 7 | 100.0% |
